| pubmed-article:19483269 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19483269 | lifeskim:mentions | umls-concept:C0035696 | lld:lifeskim |
| pubmed-article:19483269 | lifeskim:mentions | umls-concept:C0019398 | lld:lifeskim |
| pubmed-article:19483269 | lifeskim:mentions | umls-concept:C0035669 | lld:lifeskim |
| pubmed-article:19483269 | lifeskim:mentions | umls-concept:C0035681 | lld:lifeskim |
| pubmed-article:19483269 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:19483269 | lifeskim:mentions | umls-concept:C2599806 | lld:lifeskim |
| pubmed-article:19483269 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:19483269 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19483269 | pubmed:dateCreated | 2009-6-1 | lld:pubmed |
| pubmed-article:19483269 | pubmed:abstractText | An unusual feature of influenza viral -messenger RNA (mRNA) synthesis is its dependence upon host cell mRNAs as a source of capped RNA primers. A crucial activity of the influenza polymerase is to steal these primers by binding and cleaving the caps from host mRNAs. The recent structural analysis of the cap-binding fragment of the influenza virus PB2 protein has highlighted the importance of the mesoionic properties of the N7-methylguanine (N(7m)G) component of the mRNA cap in this interaction. | lld:pubmed |
| pubmed-article:19483269 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19483269 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19483269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19483269 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19483269 | pubmed:issn | 2040-2066 | lld:pubmed |
| pubmed-article:19483269 | pubmed:author | pubmed-author:GengFengF | lld:pubmed |
| pubmed-article:19483269 | pubmed:author | pubmed-author:TileyLaurence... | lld:pubmed |
| pubmed-article:19483269 | pubmed:author | pubmed-author:MickleburghIa... | lld:pubmed |
| pubmed-article:19483269 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19483269 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:19483269 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19483269 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19483269 | pubmed:pagination | 213-8 | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:meshHeading | pubmed-meshheading:19483269... | lld:pubmed |
| pubmed-article:19483269 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19483269 | pubmed:articleTitle | Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity. | lld:pubmed |
| pubmed-article:19483269 | pubmed:affiliation | Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. | lld:pubmed |
| pubmed-article:19483269 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19483269 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19483269 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
